FtsZ as a novel target for antibiotics development: Promises and challenges

Area of Science:

• Microbiology
• Drug Discovery
• Structural Biology

Background:

• Filamenting temperature-sensitive mutant Z (FtsZ) is essential for bacterial cell division and absent in humans, making it a prime antibiotic target.
• Over 100 compounds targeting FtsZ have been identified, but limited chemical diversity and drug resistance pose significant challenges.

Purpose of the Study:

• To review the current landscape of FtsZ inhibitors and identify strategies to overcome challenges in developing clinically viable antibiotics.
• To highlight the need for novel approaches to address antibiotic resistance.

Main Methods:

• Biochemical assays (e.g., GTPase activity) and cellular approaches (e.g., immunofluorescence) were used to identify FtsZ inhibitors.
• Structural studies including X-ray crystallography and cryo-electron microscopy were employed to understand FtsZ structure and function.
• Cheminformatics clustering was used to analyze the chemical diversity of identified compounds.

Main Results:

• A limited chemical diversity among current FtsZ inhibitor scaffolds was observed.
• Structural studies revealed conserved polymerization mechanisms and conformational plasticity in FtsZ.
• Clinical translation is hindered by weak binding, inefficacy, and evolving drug resistance.

Conclusions:

• Future efforts should focus on resolving transient assembly intermediates and utilizing machine learning with high-throughput screening.
• Integrating structural biology with pharmacokinetic optimization is essential for drug development.
• Multidisciplinary strategies are promising for translating FtsZ research into effective therapies against antibiotic resistance.